Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Olaf Brouwers"'
Autor:
Casper G. Schalkwijk, Coen D. A. Stehouwer, Geja Hageman, Ben J. A. Janssen, Frans van Nieuwenhoven, Toshio Miyata, Joyce M. J. de Vos-Houben, Petra M. G. Niessen, Olaf Brouwers
Publikováno v:
International Journal of Molecular Sciences, Vol 14, Iss 8, Pp 15724-15739 (2013)
Diabetes significantly increases the risk of heart failure. The increase in advanced glycation endproducts (AGEs) and oxidative stress have been associated with diabetic cardiomyopathy. We recently demonstrated that there is a direct link between AGE
Externí odkaz:
https://doaj.org/article/ceb6ef4724a847b88ccf4d6b59408122
Autor:
Marc van Bilsen, Anneleen Daniels, Olaf Brouwers, Ben J A Janssen, Wouter J A Derks, Agnieszka E Brouns, Chantal Munts, Casper G Schalkwijk, Ger J van der Vusse, Frans A van Nieuwenhoven
Publikováno v:
PLoS ONE, Vol 9, Iss 1, p e85078 (2014)
BACKGROUND: Type 2 diabetes is frequently associated with co-morbidities, including hypertension. Here we investigated if hypertension is a critical factor in myocardial remodeling and the development of cardiac dysfunction in type 2 diabetic db/db m
Externí odkaz:
https://doaj.org/article/0971133d3b4e4f369d73c74685f0d613
Autor:
Toshio Miyata, Maya S. P. Huijberts, Petra Niessen, Mark J. Post, Liang Yu, Olaf Brouwers, Casper G. Schalkwijk, Jos Slenter, Allard Wagenaar, Walter H. Backes, Karolien Jaspers, Coen D.A. Stehouwer
Publikováno v:
Glycoconjugate Journal, 33(4), 627-630. Springer
Glycoconjugate Journal
Glycoconjugate Journal
We hypothesize that diabetes-induced impaired collateral formation after a hindlimb ligation in rats is in part caused by intracellular glycation and that overexpression of glyoxalase-I (GLO-I), i.e. the major detoxifying enzyme for advanced-glycatio
Autor:
Ben J. A. Janssen, Coen D.A. Stehouwer, Olaf Brouwers, Katrien H.J. Gaens, Kristiaan Wouters, Casper G. Schalkwijk, Toshio Miyata, Jack P.M. Cleutjens, Dionne E. Maessen
Publikováno v:
Diabetes, 65(4), 956-966. American Diabetes Association
Obesity is associated with an increased risk for the development of type 2 diabetes and vascular complications. Advanced glycation end products are increased in adipose tissue and have been associated with insulin resistance, vascular dysfunction, an
Autor:
Jack P.M. Cleutjens, Erwin Wijnands, Marion J.J. Gijbels, Jo G. R. De Mey, Erik A.L. Biessen, Kristiaan Wouters, Toshio Miyata, Olaf Brouwers, Coen D.A. Stehouwer, Casper G. Schalkwijk, Nordin M J Hanssen
Publikováno v:
Cardiovascular Research, 104(1), 160-170. Oxford University Press
Cardiovascular research, 104(1), 160-170. Oxford University Press
Hanssen, N M J, Brouwers, O, Gijbels, M J, Wouters, K, Wijnands, E, Cleutjens, J P M, De Mey, J G, Miyata, T, Biessen, E A, Stehouwer, C D A & Schalkwijk, C G 2014, ' Glyoxalase 1 overexpression does not affect atherosclerotic lesion size and severity in ApoE-/-mice with or without diabetes ', Cardiovascular Research, vol. 104, no. 1, pp. 160-170 . https://doi.org/10.1093/cvr/cvu189
Cardiovascular research, 104(1), 160-170. Oxford University Press
Hanssen, N M J, Brouwers, O, Gijbels, M J, Wouters, K, Wijnands, E, Cleutjens, J P M, De Mey, J G, Miyata, T, Biessen, E A, Stehouwer, C D A & Schalkwijk, C G 2014, ' Glyoxalase 1 overexpression does not affect atherosclerotic lesion size and severity in ApoE-/-mice with or without diabetes ', Cardiovascular Research, vol. 104, no. 1, pp. 160-170 . https://doi.org/10.1093/cvr/cvu189
AIMS: Advanced glycation end-products (AGEs) and their precursors have been associated with the development of atherosclerosis. We recently discovered that glyoxalase 1 (GLO1), the major detoxifying enzyme for AGE precursors, is decreased in ruptured
Autor:
Olaf Brouwers, Tom Teerlink, Toshio Miyata, Petra Niessen, Peter G. Scheffer, Casper G. Schalkwijk, Michael Brownlee, Coen D.A. Stehouwer, Isabel Ferreira, Patrick Schrauwen
Publikováno v:
Journal of Biological Chemistry, 286(2), 1374-1380. American Society for Biochemistry and Molecular Biology Inc.
Journal of Biological Chemistry, 286(2), 1374-1380. American Society for Biochemistry and Molecular Biology, Inc.
Brouwers, O, Niessen, P M, Ferreira, I, Miyata, T, Scheffer, P G, Teerlink, T, Schrauwen, P, Brownlee, M, Stehouwer, C D A & Schalkwijk, C G 2011, ' Overexpression of Glyoxalase-I Reduces Hyperglycemia-induced Levels of Advanced Glycation End Products and Oxidative Stress in Diabetic Rats ', Journal of Biological Chemistry, vol. 286, no. 2, pp. 1374-1380 . https://doi.org/10.1074/jbc.M110.144097
Journal of Biological Chemistry, 286(2), 1374-1380. American Society for Biochemistry and Molecular Biology, Inc.
Brouwers, O, Niessen, P M, Ferreira, I, Miyata, T, Scheffer, P G, Teerlink, T, Schrauwen, P, Brownlee, M, Stehouwer, C D A & Schalkwijk, C G 2011, ' Overexpression of Glyoxalase-I Reduces Hyperglycemia-induced Levels of Advanced Glycation End Products and Oxidative Stress in Diabetic Rats ', Journal of Biological Chemistry, vol. 286, no. 2, pp. 1374-1380 . https://doi.org/10.1074/jbc.M110.144097
The reactive advanced glycation end product (AGE) precursor methylglyoxal (MGO) and MGO-derived AGEs are associated with diabetic vascular complications and also with an increase in oxidative stress. Glyoxalase-I (GLO-I) transgenic rats were used to
Autor:
Giel Nijpels, Carla J.H. van der Kallen, Ellen E. Blaak, L. Engelen, Olaf Brouwers, Ronald M.A. Henry, Robert J. Heine, Marleen M.J. van Greevenbroek, Casper G. Schalkwijk, Hugo ten Cate, Edith J. M. Feskens, Coen D.A. Stehouwer, Isabel Ferreira, Jacqueline M. Dekker
Publikováno v:
Journal of Hypertension 27 (2009) 7
Journal of Hypertension, 27(7), 1399-1403
Engelen, L, Ferreira, I, Brouwers, O, Henry, R M A, Dekker, J M, Nijpels, M G A A M, Heine, R J, van Greevenbroek, M M J, van der Kallen, C J H, Blaak, E E, Feskens, E J M, Ten Cate, H, Stehouwer, C D A & Schalkwijk, C 2009, ' Polymorphisms in glyoxalase 1 gene are not associated with vascular complications: the Hoorn and CoDAM studies ', Journal of Hypertension, vol. 27, no. 7, pp. 1399-1403 . https://doi.org/10.1097/HJH.0b013e32832af6ba
Journal of Hypertension, 27(7), 1399-1403. Lippincott Williams and Wilkins
Journal of Hypertension, 27(7), 1399-1403
Engelen, L, Ferreira, I, Brouwers, O, Henry, R M A, Dekker, J M, Nijpels, M G A A M, Heine, R J, van Greevenbroek, M M J, van der Kallen, C J H, Blaak, E E, Feskens, E J M, Ten Cate, H, Stehouwer, C D A & Schalkwijk, C 2009, ' Polymorphisms in glyoxalase 1 gene are not associated with vascular complications: the Hoorn and CoDAM studies ', Journal of Hypertension, vol. 27, no. 7, pp. 1399-1403 . https://doi.org/10.1097/HJH.0b013e32832af6ba
Journal of Hypertension, 27(7), 1399-1403. Lippincott Williams and Wilkins
OBJECTIVES: Methylglyoxal is a major precursor in the formation of advanced glycation endproducts (AGEs), which are known to contribute to vascular complications such as hypertension and arterial stiffness. Methylglyoxal can be detoxified by glyoxala
Publikováno v:
Nederlands Tijdschrift voor Diabetologie. 11:145-146
Obesity is characterized by a dysregulation of pro- and anti-inflammatory adipokines which are involved in the pathogenesis of obesity-related insulin resistance and type 2 diabetes. We showed that the advanced glycation endproduct (AGE), Ne-(Carboxy
Autor:
Coen D.A. Stehouwer, Casper G. Schalkwijk, Mark J. Post, Walter H. Backes, Liang Yu, Jos Slenter, Allard Wagenaar, Olaf Brouwers, Maya S. P. Huijberts, Petra Niessen
Publikováno v:
Nederlands Tijdschrift voor Diabetologie. 9:99-100
Arteriogenesis is an important mechanism in improving the outcome of ischemic vascular diseases. However in patients who suffer from diabetes, this compensational collateral capacity is impaired. Hyperglycemia is the initial factor of diabetes induce
Autor:
Michael Brownlee, J. G. R. De Mey, Casper G. Schalkwijk, Olaf Brouwers, Petra Niessen, Toshio Miyata, Guido R.M.M. Haenen, Coen D.A. Stehouwer
Publikováno v:
Diabetologia, 53(5), 989-1000. Springer, Cham
Diabetologia
Diabetologia
Aims/hypothesis Impaired nitric oxide (NO)-dependent vasorelaxation plays a key role in the development of diabetic vascular complications. We investigated the effect of hyperglycaemia on impaired vasoreactivity and a putative role therein of the AGE